Medtronic Stock: Partnership with Michael J. Fox Foundation Announced - Börse Express
Article excerpt
Highlighted: the sentence this signal was extracted from
Medtronic announced an educational partnership with the Michael J. Fox Foundation on Wednesday. The joint offering is intended to help people with Parkinson's disease better understand deep brain stimulation. It is also aimed at relatives and caregivers and includes an online information offering, a guide, and webinars. The initiative comes alongside new clinical communications and the company's upcoming quarterly report. On the stock market on Friday, however, Medtronic lagged behind several competitors, as media reports on the trading session show. The stock fell by 2.1% to €91.54 on Friday. Reports on its weaker performance compared to competitors did not cite any company-specific trigger. The Associated Press described US stock trading on Friday as mixed following a volatile week. In the S&P 500, more stocks declined than advanced. As early as Thursday, artificial intelligence-related stocks in particular had led the broad sell-off. The reporting did not establish a concrete connection to Medtronic's price loss. About two weeks ago, Medtronic presented positive six-month data from the real-world SPYRAL AFFIRM study for its Symplicity Spyral renal denervation system. According to the company, the FDA also approved an expansion of the US product labeling to include clinical data for additional patient groups. These include people with isolated systolic hypertension...
Keep reading with a free account
The rest of this article, and every signal for Medtronic, is in your free account.
